Thoracic complications of liver cirrhosis: Radiologic findings

Radiographics

Volumn 29, Issue 3, 2009, Pages 825-837

  Kim, Yoon Kyung ^a,b   Kim, Yookyung ^a   Shim, Sung Shine ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; CARDIOVASCULAR DISEASE; COLLATERAL CIRCULATION; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATOPULMONARY SYNDROME; HUMAN; HYDROTHORAX; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; LUNG DISEASE; MALE; MIDDLE AGED; PORTAL HYPERTENSION; PULMONARY HYPERTENSION; RADIOGRAPHY; REVIEW; SARCOIDOSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CARDIOVASCULAR DISEASES; COLLATERAL CIRCULATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; HYDROTHORAX; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER CIRRHOSIS; LIVER NEOPLASMS; LUNG DISEASES; MALE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; SARCOIDOSIS;

EID: 68549092916     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.293085093     Document Type: Article

References (48)

1. Huffmyer JL, Nemergut EC. Respiratory dysfunction and pulmonary disease in cirrhosis and other hepatic disorders. Respir Care 2007;52:1030-1036.
2. King PD, Rumbaut R, Sanchez C. Pulmonary manifestations of chronic liver disease. Dig Dis 1996;14: 73-82.
3. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: current concepts in diagnostic and therapeutic considerations. Chest 1994;105:1528-1537.
4. Meyer CA, White CS, Sherman KE. Diseases of the hepatopulmonary axis. RadioGraphics 2000; 20:687-698.
5. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521-529.
6. Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol 2005;39(4 suppl 2): S138-S142.
7. Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver: lung spider nevi. N Engl J Med 1966;274:291-298.
8. Williams A, Trewby P, Williams R, Reid L. Structural alterations to the pulmonary circulation in fulminant hepatic failure. Thorax 1979;34:447-453.
9. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993;104:515-521.
10. McAdams HP, Erasmus J, Crockett R, Mitchell J, Godwin JD, McDermott VG. The hepatopulmonary syndrome: radiologic findings in 10 patients. AJR Am J Roentgenol 1996;166:1379-1385.
11. Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004;24:861-880.
12. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004;363:1461-1468.
13. Tan RT, Kuzo R, Goodman LR, et al. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest 1998;113:1250-1256.
14. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999;14:270-278.
15. Sherrick AD, Swensen SJ, Hartman TE. Mosaic pattern of lung attenuation on CT scans: frequency among patients with pulmonary artery hypertension of different causes. AJR Am J Roentgenol 1997; 169:79-82.
16. Fukuchi K, Hayashida K, Nakanishi N, et al. Quantitative analysis of lung perfusion in patients with primary pulmonary hypertension. J Nucl Med 2002;43:757-761.
17. Wachsberg RH, Yaghmai V, Javors BR, Levine CD, Simmons MZ, Maldjian PD. Cardiophrenic varices in portal hypertension: evaluation with CT. Radiology 1995;195:553-556.
18. Kim YJ, Raman SS, Yu NC, To'o KJ, Jutabha R, Lu DS. Esophageal varices in cirrhotic patients: evaluation with liver CT. AJR Am J Roentgenol 2007; 188:139-144.
19. Lee SJ, Lee KS, Kim SA, Kim TS, Whang JH, Lim JH. Computed radiography of the chest in patients with paraesophageal varices: diagnostic accuracy and characteristic findings. AJR Am J Roentgenol 1998;170:1527-1531.
20. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001;120: 726-748.
21. Kim SH, Kim YJ, Lee JM, et al. Esophageal varices in patients with cirrhosis: multidetector CT esophagography-comparison with endoscopy. Radiology 2007;242:759-768.
22. Chung JW, Im JG, Park JH, Han JK, Choi CG, Han MC. Left paracardiac mass caused by dilated pericardiacophrenic vein: report of four cases. AJR Am J Roentgenol 1993;160:25-28.
23. Cardenas A, Arroyo V. Management of ascites and hepatic hydrothorax. Best Pract Res Clin Gastroenterol 2007;21:55-75.
24. Roussos A, Philippou N, Mantzaris GJ, Gourgouliannis KI. Hepatic hydrothorax: pathophysiology diagnosis and management. J Gastroenterol Hepatol 2007;22:1388-1393.
25. Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999;107:262-267.
26. Kaplan LM, Epstein SK, Schwartz SL, Cao QL, Pandian NG. Clinical, echocardiographic, and hemodynamic evidence of cardiac tamponade caused by large pleural effusions. Am J Respir Crit Care Med 1995;151:904-908.
27. Xiol X, Castellote J, Cortes-Beut R, Delgado M, Guardiola J, Sese E. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med 2001;111:67-69.
28. Monchi M, Bellenfant F, Cariou A, et al. Early predictive factors of survival in the acute respiratory distress syndrome: a multivariate analysis. Am J Respir Crit Care Med 1998;158:1076-1081.
29. TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest 2001;119:1179-1184.
30. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury: predictors of mortality. Am J Respir Crit Care Med 1995;152:1818-1824.
31. Goodman LR, Fumagalli R, Tagliabue P, et al. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlations. Radiology 1999;213: 545-552.
32. Cheruvattath R, Balan V. Infections in patients with end-stage liver disease. J Clin Gastroenterol 2007; 41:403-411.
33. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993;18:353-358.
34. Propst-Graham KL, Preheim LC, Vander Top EA, Snitily MU, Gentry-Nielsen MJ. Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae. BMC Microbiol 2007;7:94.
35. Xiol X, Castellvi JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996;23:719-723.
36. Cho YJ, Lee SM, Yoo CG, et al. Clinical characteristics of tuberculosis in patients with liver cirrhosis. Respirology 2007;12:401-405.
37. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127(5 suppl 1):S35-S50.
38. Boiskin I, Marsan RE, Boles M, Jacobs WR, Demos TC. Hepatocellular carcinoma with intraatrial extension. Cardiovasc Intervent Radiol 1997; 20:324-327.
39. Wilson K, Guardino J, Shapira O. Pulmonary tumor embolism as a presenting feature of cavoatrial hepatocellular carcinoma. Chest 2001;119: 657-658.
40. Didier D, Racle A, Etievent JP, Weill F. Tumor thrombus of the inferior vena cava secondary to malignant abdominal neoplasms: US and CT evaluation. Radiology 1987;162:83-89.
41. Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T, Kawasaki H. Hepatocellular carcinoma with intra-atrial tumor growth: a clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med 1984;108:989-992.
42. Ishiguro T, Kasahara K, Matsumoto I, et al. Primary pulmonary artery sarcoma detected with a pulmonary infarction. Intern Med 2007;46:601-604.
43. Ramos-Casals M, Mana J, Nardi N, et al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 2005;84:69-80.
44. Rubinowitz AN, Naidich DP, Alinsonorin C. Interferon-induced sarcoidosis. J Comput Assist Tomogr 2003;27:279-283.
45. Conlon KC, Urba WJ, Smith JW 2nd, Steis RG, Longo DL, Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving alphainterferon therapy. Cancer 1990;65:2237-2242.
46. Pietropaoli A, Modrak J, Utell M. Interferon-alpha therapy associated with the development of sarcoidosis. Chest 1999;116:569-572.
47. Sharma A, Provenzale D, McKusick A, Kaplan MM. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology 1994;107:266-270.
48. Arakawa H, Yamasaki M, Kurihara Y, Yamada H, Nakajima Y. Methotrexate-induced pulmonary injury: serial CT findings. J Thorac Imaging 2003; 18:231-236.